Temasek Holdings (Private) Ltd

Holdings History for Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA)

Symbol: NTLA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2025		-0.01%	$0	0	-279,693	-100%	$14.28	Q1 2025
31 Dec 2024	0.01%	0%	$3,261,220	279,693	0		$11.66	Q4 2024
30 Sep 2024	0.02%	0%	$5,747,691	279,693	0		$20.55	Q3 2024
30 Jun 2024	0.03%	0%	$6,259,529	279,693	0		$22.38	Q2 2024
31 Mar 2024	0.04%	0%	$7,694,354	279,693	0		$27.51	Q1 2024
31 Dec 2023	0.05%	0%	$8,527,840	279,693	0		$30.49	Q4 2023
30 Sep 2023	0.05%	+0.01%	$8,843,893	279,693	+75,417	+37%	$31.62	Q3 2023
30 Jun 2023	0.05%	0%	$8,330,375	204,276	0		$40.78	Q2 2023
31 Mar 2023	0.05%	0%	$7,613,367	204,276	0		$37.27	Q1 2023
31 Dec 2022	0.04%	0%	$7,127,190	204,276	0		$34.89	Q4 2022
30 Sep 2022	0.07%	0%	$11,431,285	204,276	0		$55.96	Q3 2022
30 Jun 2022	0.06%	0%	$10,573,326	204,276	0		$51.76	Q2 2022
31 Mar 2022	0.06%	0%	$14,844,737	204,276	0		$72.67	Q1 2022
31 Dec 2021	0.09%	-0.17%	$24,154,000	204,276	-397,563	-66%	$118.24	Q4 2021
30 Sep 2021	0.28%	-0.09%	$80,737,000	601,839	-188,688	-24%	$134.15	Q3 2021
30 Jun 2021	0.43%	0%	$127,994,000	790,527	0		$161.91	Q2 2021
31 Mar 2021	0.25%	0%	$63,444,000	790,527	0		$80.26	Q1 2021
31 Dec 2020	0.18%	0%	$43,005,000	790,527	0		$54.40	Q4 2020
30 Sep 2020	0.08%	0%	$15,716,000	790,527	0		$19.88	Q3 2020
30 Jun 2020	0.1%	0%	$16,617,000	790,527	0		$21.02	Q2 2020
31 Mar 2020	0.07%	0%	$9,668,000	790,527	0		$12.23	Q1 2020
31 Dec 2019	0.08%	0%	$11,597,000	790,527	0		$14.67	Q4 2019
30 Sep 2019	0.08%	0%	$10,554,000	790,527	0		$13.35	Q3 2019
30 Jun 2019	0.09%	0%	$12,941,000	790,527	0		$16.37	Q2 2019
31 Mar 2019	0.09%	0%	$13,502,000	790,527	0		$17.08	Q1 2019
31 Dec 2018	0.07%	0%	$10,791,000	790,527	0		$13.65	Q4 2018
30 Sep 2018	0.13%	0%	$22,625,000	790,527	0		$28.62	Q3 2018
30 Jun 2018	0.11%	0%	$21,629,000	790,527	0		$27.36	Q2 2018
31 Mar 2018	0.09%	0%	$16,672,000	790,527	0		$21.09	Q1 2018
31 Dec 2017	0.09%	0%	$15,194,000	790,527	0		$19.22	Q4 2017
30 Sep 2017	0.11%	0%	$19,645,000	790,527	0		$24.85	Q3 2017
30 Jun 2017	0.08%	0%	$12,648,000	790,527	0		$16.00	Q2 2017
31 Mar 2017	0.08%	0%	$11,139,000	790,527	0		$14.09	Q1 2017
31 Dec 2016	0.08%	0%	$10,364,000	790,527	0		$13.11	Q4 2016
30 Sep 2016	0.11%	0%	$13,455,000	790,527	0		$17.02	Q3 2016
30 Jun 2016	0.13%	+0.13%	$16,878,000	790,527	+790,527	NEW	$21.35	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.